All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

278

Reset

278 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • CRT-402Phase 21 trial

    Myeloid Therapeutics · Autoimmune Diseases, Systemic Lupus Erythematosus, Systemic Scleroderma

  • CS32582Phase 21 trial

    Chipscreen Biosciences, Ltd. · Plaque Psoriasis

  • DA-020Phase 21 trial

    Applied Biology, Inc. · Chemotherapy Induced Alopecia, Chemotherapy Side Effects

  • DB-2304Phase 21 trial

    DualityBio Inc. · Systemic Lupus Erythematosus (SLE) or Cutaneous Lupus Erythematosus

  • DS-7011aPhase 21 trial

    Daiichi Sankyo · Systemic Lupus Erythematosus

  • E6742Phase 21 trial

    Eisai · Systemic Lupus Erythematosus

  • EB06Phase 21 trial

    Edesa Biotech Inc. · Non-Segmental Vitiligo (NSV)

  • EG-501EG-MNTP-01Phase 21 trial

    Evergreen Therapeutics, Inc. · Neuropsychiatric Systemic Lupus Erythematosus, Systemic Lupus Erythematosus (SLE), Cognitive Impairment

  • EI-001Phase 21 trial

    Elixiron Immunotherapeutics (Hong Kong) Ltd. · Non-segmental Vitiligo

  • ELV001Phase 21 trial

    Elevara Medicines Limited · Active Rheumatoid Arthritis

  • EPI-001Phase 21 trial

    Epibiotech · Androgenetic Alopecia

  • EVO301Phase 21 trial

    Evommune, Inc. · Atopic Dermatitis (AD), Eczema, Eczema Atopic Dermatitis

  • FT819Phase 21 trial

    Fate Therapeutics · Lupus Nephritis, Systemic Lupus Erythematosus, SLE - Systemic Lupus Erythematosus

  • FT839Phase 21 trial

    Fate Therapeutics · ANCA-Associated Vasculitis (AAV), Idiopathic Inflammatory Myositis (IIM), Rheumatoid Arthritis (RA)

  • GarutadustatISM5411Phase 21 trial

    InSilico Medicine Hong Kong Limited · Ulcerative Colitis

  • GenSci120Phase 21 trial

    Changchun GeneScience Pharmaceutical Co., Ltd. · Rheumatoid Arthritis

  • GHZ339Phase 21 trial

    Novartis · Atopic Dermatitis

  • HB0017Phase 21 trial

    Huabo Biopharm Co., Ltd. · Psoriasis (PsO)

  • HB0034Phase 21 trial

    Shanghai Huaota Biopharmaceutical Co., Ltd. · Generalized Pustular Psoriasis (GPP)

  • HL-300Phase 21 trial

    Hangzhou Highlightll Pharmaceutical Co., Ltd · Atopic Dermatitis

  • HLX01Phase 21 trial

    Shanghai Henlius Biotech · Membranous Nephropathy, Lupus Nephritis (LN)

  • HLX79Phase 21 trial

    Shanghai Henlius Biotech · Membranous Nephropathy, Lupus Nephritis (LN)

  • HRS-3095Phase 21 trial

    Chengdu Suncadia Medicine Co., Ltd. · Chronic Spontaneous Urticaria

  • HRS-7085Phase 21 trial

    Shandong Suncadia Medicine Co., Ltd. · Adult Patients With Moderately to Severely Active Ulcerative Colitis

  • HS-10374Phase 21 trial

    Hansoh BioMedical R&D Company · Psoriasis

  • HS-10561Phase 21 trial

    Jiangsu Hansoh Pharmaceutical Co., Ltd. · Chronic Spontaneous Urticaria

  • HS-20118Phase 21 trial

    Jiangsu Hansoh Pharmaceutical Co., Ltd. · Moderate to Severe Plaque Psoriasis

  • HW201877Phase 21 trial

    Hubei Bio-Pharmaceutical Industrial Technological Institute Inc. · Inflammatory Bowel Disease (IBD)

  • HXN6005Phase 21 trial

    Helixon Biotechnology (Suzhou) Co., Ltd · Health Adult Subjects, Atopic Dermatitis (AD)

  • IBI3002Phase 21 trial

    Innovent Biologics (Suzhou) Co. Ltd. · Atopic Dermatitis

  • IBI355Phase 21 trial

    Innovent Biologics (Suzhou) Co. Ltd. · Sjögren's Disease

  • INT-210Phase 21 trial

    Innatus Therapeutics (Shanghai) Co., Ltd. · Ulcerative Colitis (UC)

  • iscalimabCFZ533Phase 21 trial

    Novartis · Hidradenitis Suppurativa

  • JNJ-88545223Phase 21 trial

    Johnson & Johnson (Janssen) · Arthritis, Psoriatic

  • LAD191Phase 21 trial

    Almirall, S.A. · Hidradenitis Suppurativa

  • LAD328Phase 21 trial

    Almirall, S.A. · Hidradenitis Suppurativa

  • LAD603Phase 21 trial

    Almirall, S.A. · Alopecia Areata

  • LEO 138559LEO 138559 is also called "temtokibart"Phase 21 trial

    LEO Pharma · Atopic Dermatitis

  • LesigerceptPhase 21 trial

    Yuhan Corporation · Allergic Diseases, Chronic Spontaneous Urticaria (CSU)

  • LY3871801Phase 21 trial

    Eli Lilly · Rheumatoid Arthritis

  • LY3972406Phase 21 trial

    Eli Lilly · Plaque Psoriasis

  • LY4100511Phase 21 trial

    DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company · Plaque Psoriasis

  • LYS006Phase 21 trial

    Novartis · Hidradenitis Suppurativa

  • MB-001Phase 21 trial

    Mage Biologics · Ulcerative Colitis (UC)

  • MGT-006Phase 21 trial

    Metagen Therapeutics, Inc. · Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate

  • MK-8690PRA052Phase 21 trial

    Merck & Co. · Colitis Ulcerative, Ulcerative Colitis

  • MT-201Phase 21 trial

    Mirador Therapeutics, Inc. · Inflammatory Bowel Disease (IBD), Ulcerative Colitis (UC), Crohn's Disease

  • MT-501Phase 21 trial

    Mirador Therapeutics, Inc. · Inflammatory Bowel Disease (IBD), Ulcerative Colitis (UC), Crohn's Disease

  • NAV-240Phase 21 trial

    Navigator Medicines, Inc. · Hidradenitis Suppurativa (HS)

  • NN2802Phase 21 trial

    Novelty Nobility, Inc. · Healhty, Chronic Spontaneous Urticaria (CSU)

NewerPage 5 of 6Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.